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Metastatic disease involving the eye is rare. In women, the primary 
cancer most commonly occurs in the breast. Ocular metastases from 
breast cancer are generally a feature of widespread disseminated 
disease. It is rare for ophthalmological symptoms to be the presenting 
symptoms of a breast primary carcinoma. We present two patients 
who were not known to have breast cancer and who were diagnosed 
with ocular metastases, which were subsequently shown to be from a 
breast primary lesion.
Case 1
A 74-year-old woman presented to her ophthalmologist with a 
4-week history of deteriorating vision in her right eye. She noticed 
flashing lights for the first 2 weeks, followed by 2 weeks of decreased 
visual acuity. 
On examination, the visual acuity on the right was 0.4 best 
corrected (left: 1.0) and the anterior segment was normal.
The dilated pupil fundus examination revealed exudative retinal 
detachment (retinal detachment with no visible retinal tears, holes 
or breaks) with subretinal haemorrhage and a choroidal mass ~2 disc 
diameters superior from her optic disc (Fig. 1).
The mass was provisionally diagnosed as a choroidal secondary 
lesion, as it did not appear to be a choroidal melanoma. The patient 
initially reported to be well, but on further questioning with regard to 
comorbidities she mentioned noticing a breast lump.
On examination of her breasts, she had locally advanced breast 
cancer of the left breast with overlying skin nodules and ipsilateral 
lymphadenopathy. Core biopsy showed the lesion to be grade 3 ductal 
carcinoma – oestrogen receptor (ER)-positive, progesterone receptor 
(PR)-positive, HER2-negative. A computed tomography (CT) scan 
showed an intraocular lesion with widespread pulmonary and bony 
metastases. She was treated with endocrine therapy.
Case 2
An 80-year-old woman presented to her ophthalmologist with a 
1-month history of blurred vision in her right eye. The vision was 
reduced to 6/18 and she had a large pale subretinal lesion nasal 
to the disc. She was otherwise well. An ultrasound scan of the eye 
showed a single, 14 mm choroidal mass (Fig. 2). Magnetic resonance 
imaging (MRI) confirmed an intraocular mass (Fig. 3), in keeping 
with a metastatic lesion. She was unaware of any other problems. 
On examination, her breasts were normal. Her mammogram showed 
a 6 mm lesion in the left breast. Biopsy revealed a grade 1 ER-positive, 
PR-positive, HER2-negative ductal carcinoma. A CT scan showed 
multiple pulmonary metastases and an adrenal mass. These were 
interpreted in keeping with metastatic breast cancer rather than 
melanoma. She was treated with an aromatase inhibitor and her 
vision has improved.
Background
The presenting symptoms of ocular tumours are blurred vision, loss 
of peripheral vision or floaters. 
The differential diagnosis includes:
• choroidal melanoma
• choroidal metastases (commonly breast and lung)
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Two patients presented to their ophthalmologists with vision disturbances. On ocular examination, retinopathic lesions were observed. 
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complaint.
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Fig. 1. Fundoscopy showing retinal folds with retinal detatchment, and no 
obvious tear.
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• choroidal haemorrhage
• inflammatory lesions of the choroid (granulomatous diseases)
• retinoblastoma (in children).
Orbital tumours tend to present differently. The common presenting 
symptoms are proptosis, pain, diplopia and blurred vision. 
The differential diagnosis includes:
• orbital pseudotumour
• thyroid eye disease
• haemangioma
• meningioma
• lymphoma
• rhabdomyosarcoma
• metastases.
Discussion
The eye is an uncommon site for metastatic lesions, as it does 
not have a well-developed lymphatic system. Therefore, metastatic 
spread to the eye is haematogenous. The uveal tract, which is the 
most vascular part of the eye, is the most likely to be affected.[1] 
Ninety percent of metastatic lesions deposit in the choroid, causing 
painless loss of vision. The most common presentations are blurred 
vision, visual field defects and floaters.[2-4] In ~10% of cases the iris 
and ciliary body are involved.[1,3] In such cases, patients present with 
chronic anterior uveitis or raised intraocular pressure owing to iris 
neovascularisation or trabecular meshwork block from metastatic 
deposits.[1] The inflammation and raised pressure are resistant to 
treatment. Less commonly, breast adenocarcinoma will deposit 
in the orbital lymphatic tissue behind the eye and present with 
exophthalmos and pain.[2,4] 
On examination, choroidal metastases appear as pale subretinal 
lesions. The lesions exude serous fluid into the subretinal space 
and frequently cause retinal detachment. Choroidal metastases are 
associated with a disproportionately large amount of subretinal 
fluid compared with primary choroidal melanomas.[1,3,5] Both of 
our patients had retinal detachment at presentation, which is not 
uncommon in women with metastatic breast cancer. In contrast, 
with melanomas, the deposit is usually of a significant size before an 
exudative retinal detachment can be seen. 
Many choroidal metastases are asymptomatic, unless the macula 
is directly involved by tumour or the associated retinal detachment. 
They tend to be pale and often have a characteristic leopard-spot 
appearance from retinal pigment epithelial change on the surface. 
Lipofuscin from poorly functioning retinal pigment epithelium can 
be observed on the surface of metastatic deposits, which can also be 
seen in choroidal melanoma.[1] Fluorescein angiography of a meta-
static deposit reveals hypofluoresence in the arterial phase followed 
by late hyperfluorescence, with no pooling of dye. Indocyanine green 
angiography of the deeper choroidal vasculature is useful to differenti-
ate choroidal haemangioma from a metastatic deposit. However, the 
most helpful investigation is an ocular ultrasound scan. Metastases are 
typically placoid shaped with an undulating surface and show medium 
to high blood flow velocity. 
Most ocular metastases are indistinguishable in terms of the original 
primary tumour; however, certain primary tumours are associated 
with a particular metastatic appearance. Carcinoid metastases in the 
choroid appear orange, as do thyroid metastases. Renal metastases 
are more likely to produce intraocular haemorrhage. A solitary ocular 
metastasis from a cutaneous melanoma is pigmented and difficult to 
distinguish from a primary choroidal melanoma, although retinal 
and vitreous pigmented seeding is an indication that the pigmented 
choroidal tumour may be a secondary lesion.
When investigating ocular tumours, a breast examination and 
chest radiograph should be performed to determine the possible 
presence of a primary lesion. A liver ultrasound scan and liver 
function tests should be done to investigate the presence of potential 
liver metastases. An MRI of the brain is an important investigation, 
as cerebral and intraocular cancers often coexist. If the primary 
source of the metastatic lesion is unknown, a positron emission 
tomography (PET) scan or CT scan should be considered. These 
are very helpful investigations for lymphoma and melanoma, 
which are metabolically active and therefore show good uptake of 
fludeoxyglucose F18 (FDG).[1]
The proportion of ocular tumours caused by metastases depends 
on when the tumours are diagnosed. A survey of 716 patients 
with ocular disease leading to their death showed that 9.3% had 
metastatic disease to the eye. However, this is more commonly seen 
at postmortem examination than in routine practice.[1] Common 
primary sites include breast (47%) and lung (21%). Other primary 
sites are prostate, gastrointestinal tract, kidney and skin (melanoma).[6] 
The metastases usually present as unilateral disease.[2] However, bilateral 
disease does occur, with an incidence of 20%.[7]
Fig. 3. Magnetic resonance imaging showing intraocular tumour.
Fig. 2. Ultrasound scan showing ocular tumour.
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In women with widespread metastatic breast cancer, 28 - 58% may 
have orbital metastases[1,6] that may be asymptomatic. The metastases 
generally present 4.5 - 6.5 years after the initial diagnosis.[7]
However, ocular metastasis is seldom the initial presentation of a 
previously undetected cancer. 
Conclusion
Although ocular metastases as primary presentation of breast cancer 
are rare, it is an important diagnosis to consider. When examining a 
patient with ophthalmological complaints suggesting an infiltrative 
process, a thorough history must be taken and, in women, a full 
clinical examination must include a breast examination.
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